Village-Neuf, France

Sandra Marie Joseph Grall-Ulsemer

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Hoffmann-La Roche Inc.. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sandra Marie Joseph Grall-Ulsemer. Retrieved from https://idiyas.com/inventor/sandra-marie-joseph-grall-ulsemer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Journey of Sandra Marie Joseph Grall-Ulsemer

Introduction: Sandra Marie Joseph Grall-Ulsemer is a prominent inventor based in Village-Neuf, France. With a significant contribution to the pharmaceutical field, she holds a patent that showcases her commitment to addressing critical health issues. Her journey as an inventor reflects the blend of creativity and scientific inquiry that drives innovation in modern medicine.

Latest Patents: Sandra's notable patent focuses on heterocyclic compounds. This invention introduces novel heterocyclic compounds characterized by the general formula (I) along with their pharmaceutically acceptable salts. The patent further details pharmaceutical compositions comprising these compounds, outlining processes for manufacturing them and their application as medicaments. Specifically, this innovation is geared towards treating or preventing bacterial infections, marking a vital advancement in antibiotic therapies.

Career Highlights: Sandra has made significant strides in her career, working with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. Her expertise and innovative mindset have contributed to the development of important medical treatments, highlighting her role in advancing healthcare solutions.

Collaborations: Throughout her career, Sandra has collaborated with talented colleagues such as Mathis Braendlin and Xingchun Han. These partnerships foster an environment of collective innovation and problem-solving, essential for the growth and success of new inventions in the medical field.

Conclusion: Sandra Marie Joseph Grall-Ulsemer exemplifies the spirit of innovation that drives the pharmaceutical industry forward. Her contributions through her patent on heterocyclic compounds underscore the importance of scientific research and collaboration in developing effective medical solutions. As she continues her work, her impact is sure to resonate within the realms of medicine and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…